These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4619737)

  • 1. [Determination of Clostridium boltulinum toxins using passive hemagglutination].
    Franke F
    Zentralbl Veterinarmed B; 1974 Sep; 21(9):660-76. PubMed ID: 4619737
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antigenic structure of Cl. botulinum types E and F].
    Bulatova TI; Perova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Apr; 47(4):28-32. PubMed ID: 4920529
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking of antibody passive hemagglutination reaction (Bl-AbHAp) as a test for in vitro recognition of type-specific soluble antigens of Clostridium botulinum.
    Ligieza J; Reiss J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):183-7. PubMed ID: 3539066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.
    Sakaguchi G; Sakaguchi S; Kozaki S; Sugii S; Oishi I
    Jpn J Med Sci Biol; 1974 Jun; 27(3):161-72. PubMed ID: 4604281
    [No Abstract]   [Full Text] [Related]  

  • 6. [Factors limiting the passive hemagglutination reaction: trials using botulin toxin and anatoxin].
    Stellmann C; Branche R; Roumiantzeff M
    Pathol Biol; 1968 Jan; 16(1):47-51. PubMed ID: 4869419
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic and chromatographic identity of two apparently distinct toxins of Clostridium botulinum type A.
    Hauschild AH; Hilsheimer R
    Can J Microbiol; 1969 Oct; 15(10):1129-32. PubMed ID: 4905857
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of Clostridium botulinum in soil samples by means of immunodiffusion].
    Brantner H; Dohmen H
    Arch Hyg Bakteriol; 1969 Jun; 153(3):239-43. PubMed ID: 4985401
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent observations on the toxins of Clostridium botulinum, with special reference to type E].
    Sakaguchi G
    Tanpakushitsu Kakusan Koso; 1968 Sep; 13(10):921-8. PubMed ID: 4883374
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of prednisolone, periston-N and antitoxic serum on the absorption and localization of I-131-labelled Clostridium botulinum B toxin in guinea pigs].
    Stempień R; Fabianowski J; Ubysz-Jerzmanowska K; Brühl A
    Pol Tyg Lek; 1967 May; 22(18):665-8. PubMed ID: 4865249
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemagglutination by botulinal toxin.
    LAMANNA C
    Proc Soc Exp Biol Med; 1948 Nov; 69(2):332-6. PubMed ID: 18102220
    [No Abstract]   [Full Text] [Related]  

  • 12. Chromatographic purification of the toxin of type E Clostridium botulinum.
    Emodi AS; Lechowich RV
    Biochem Biophys Res Commun; 1969 Jun; 35(6):788-95. PubMed ID: 4893076
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clostridium botulinum type-E toxin].
    Sakaguchi G
    Nihon Saikingaku Zasshi; 1968 Mar; 23(3):155-64. PubMed ID: 4877828
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological difference between the toxin of a progeolytic strain and that of a nonproteolytic strain of Clostridium botulinum type B.
    Shimizu T; Kondo H
    Jpn J Med Sci Biol; 1973 Dec; 26(5):269-71. PubMed ID: 4601358
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of antibody to each component of Clostridium botulinum type E progenitor toxin.
    Sakaguchi G; Sakaguchi S
    Jpn J Med Sci Biol; 1973 Dec; 26(5):187-95. PubMed ID: 4601357
    [No Abstract]   [Full Text] [Related]  

  • 16. [The antigenic structure of the toxins of Clostridium botulinum, type C strains, isolated in the USSR].
    Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Aug; 42(8):79-84. PubMed ID: 5334428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of soluble antigens of type E Clostridium botulinum by gel diffusion].
    Rymkiewicz D; Albrycht H
    Med Dosw Mikrobiol; 1965; 17(4):291-7. PubMed ID: 4956463
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of botulinum toxin type by the reaction of indirect hemagglutination inhibition.
    Reiss J; Wojtyła B
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):97-108. PubMed ID: 7025794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [NONSPECIFIC REACTION OF INDIRECT HEMAGGLUTINATION IN DETECTION OF BOTULISM TOXINS IN FOOD PRODUCTS].
    BULATOVA TI
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Jan; 41():96-101. PubMed ID: 14182401
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors affecting the botulinal hemagglutination reaction, and the relationship between hemagglutinating activity and toxicity of toxin preparations.
    LOWENTHAL JP; LAMANNA C
    Am J Hyg; 1951 Nov; 54(3):342-53. PubMed ID: 14885154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.